Showing posts with label eating. Show all posts
Showing posts with label eating. Show all posts

Monday, 16 October 2023

Effectiveness of Cognitive Behaviour Therapy Targeting Eating Behaviour for Patients with Abdominal Obesity in an Ordinary Primary Health Care Setting | Chapter 8 | Novel Research Aspects in Medicine and Medical Science Vol. 8

 The purpose concerning this study is to explain in what way or manner Cognitive Behavioural Therapy Targeting Eating Behavior (CBT-TEB) was applied and to evaluate the therapy's short-term efficiency in lowering abdominal corpulence and body mass index (BMI) in routine first-contact medical care settings. Obesity is a weighty public health issue and associated with an raised risk of cardiovascular disease events and humanness. The risk of cardiovascular complications is directly had connection with excess frame fat mass and ectopic fat dethroning, but also other corpulence-related complexities such as pre-type 2 diabetes, obstructive sleep apnoea, and non-alcoholic greasy liver diseases.A screening inquiry was given to consecutive sufferers and after that a fitness dialogue, blood pressure and skin glucose check were offered. Eighty- three bodies aged 18-69 age consented to participate in the CBT-TEB invasion. Inclusion criteria were the combination of intestinal obesity and BMI ≥ 25. Primary outcome measures were changes from criterion to six months after end of remedy in waist circumference (WC), midriff-to-hip ratio (WHR), pressure, and BMI. Changes in eating behaviours: cognitive limitation eating, poignant eating and uncontrolled consuming. Obesity related psychosocial problems in addition to patients´ and group rulers´ experiences of the CBT-TEB programme were also evaluated. Pulse, systolic and diastolic blood pressure, total cholesterol, high-bulk lipoproteins (HDL-C), low-density lipoproteins (LDL-C) and triglycerides were calculated.Mean reductions after six months (total sample, last attention carried forward): WC 4.8 (sd 7.0) cm, WHR 0.027 (sd 0.04), weight 4.4 (sd 4.9) kg, BMI 1.6 (sd 1.8) kg/m2. Mean reductions afterwards six months in therapy completers: WC 5.5 (7.3) cm, WHR 0.031 (0.05), weight 5.0 (5.0) kg, BMI 1.8 (1.8) kg/m2. Cognitive limitation eating raised and uncontrolled eating, touching eating and obesity-accompanying psychosocial problems decreased considerably during remedy. Patients´ experiences of the therapy surpassed their expectations. Group leaders´ knowledge were positive. After a brief training ending, it was possible to redistribute CBT-TEB in primary care using precinct nurses and health educators as group leaders. Both cases and staff replied favorably to the treatment. The CBT-TEB program's temporary success in reducing pressure and abdominal obesity in subjects receiving first-contact medical care was pleasing and seems expected superior to the majority of different reported CBT-located programs.

Author(s) Details:

Lisbeth Stahre,
Department of Clinical Neuroscience, Section for Psychiatry, Huddinge, Karolinska Institutet, Stockholm, Sweden.

Ann Blomstrand,
Department of Primary Health Care, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Tore Hällström,
Department of Clinical Neuroscience, Section for Psychiatry, Huddinge, Karolinska Institutet, Stockholm, Sweden and Department of Neuroscience, Section of Psychiatry and Neurochemistry, Unit for Neuropsychiatric Epidemiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Please see the link here: https://stm.bookpi.org/NRAMMS-V8/article/view/12187

Friday, 8 July 2022

Determining the Feeding, Eating, and Emotional Disturbances in Children with Avoidant/Restrictive Food Intake Disorder | Chapter 2 | Emerging Challenges in Agriculture and Food Science Vol. 6

ARFID, or avoidant/restrictive food intake disorder, is a relatively recent diagnosis. The Stanford Feeding Questionnaire (SFQ), a picky eating evaluation instrument, was used to determine whether or not children with ARFID differed from control children in terms of emotional issues unrelated to eating or non-feeding. 98 control children and 50 ARFID kids were compared. The Strengths and Difficulties Questionnaire (SDQ), Screen for Child Anxiety Related Emotional Disorders (SCARED), and Sensory Responsiveness Questionnaire were completed by the parents (SRQ). The SFQ had 12 questions for problematic eating-related behaviours in children (SFQ-ARFID Scale), and additional 15 items for issues with parental feeding (SFQ-PFP Scale). These two subscales received validation for use as screening measures to determine the level of parental feeding issues and the severity of the children's eating habits (the SFQ-ARFID Scale) (the SFQ-PFP Scale). The results showed that children with ARFID had substantially higher SFQ-ARFID and SFQ-PFP Scale scores than did controls. Children with ARFID reported lower SRQ-Hedonic scores, greater SDQ-Total-Difficulties, and higher SDQ-Internalizing-Difficulties scores as compared to controls. In terms of separating children with ARFID from control children, the SFQ-ARFID Scale performed the best (area under the receiver operating characteristics curve = 0.939, 95 percent CI, 0.895-0.983, p 0.001). These results imply that, in children with ARFID compared to controls, there are more eating-related issues and emotional disturbances in addition to an increase in parental feeding issues.

The purpose of this study was to determine if a clinical diagnosis of ARFID could be supported by the use of the SFQ subscales measuring problematic eating in children (SFQ-ARFID Scale) and problematic feeding behaviours in parents (SFQ-PFP Scale). It also looked to see if there would be any differences between ARFID children and control kids in terms of their general mental state, including several particular domains (anxiety, sensory modulation), which had previously been demonstrated to be more severe in ARFID children.

Author(s) Details:

Sharon Iron-Segev,
The Robert H. Smith Faculty of Agriculture, Food and Environment, Institute of Biochemistry, Food Science and Nutrition, School of Nutritional Sciences, The Hebrew University of Jerusalem, Rehovot - 7600001, Israel and  Peres Academic Center, School of Nutritional Sciences, Rehovot - 7610202, Israel.

Danielle Best,
The Robert H. Smith Faculty of Agriculture, Food and Environment, Institute of Biochemistry, Food Science and Nutrition, School of Nutritional Sciences, The Hebrew University of Jerusalem, Rehovot - 7600001, Israel.

Shani Arad-Rubinstein,
Pediatric Psychosomatic Department, Edmond and Lily Safra Children’s Hospital, Chaim Sheba Medical Center, Tel Hashomer - 5262000, Israel.

Martin Efron,
Pediatric Psychosomatic Department, Edmond and Lily Safra Children’s Hospital, Chaim Sheba Medical Center, Tel Hashomer - 5262000, Israel.

Yaffa Serur,
Pediatric Psychosomatic Department, Edmond and Lily Safra Children’s Hospital, Chaim Sheba Medical Center, Tel Hashomer - 5262000, Israel.

Hadar Dickstein,
Pediatric Psychosomatic Department, Edmond and Lily Safra Children’s Hospital, Chaim Sheba Medical Center, Tel Hashomer - 5262000, Israel.

Daniel Stein,
Sackler Faculty of Medicine Tel Aviv University, Tel Aviv - 6997801, Israel.